Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI Q2 2025 earnings

Reported August 11, 2025 · After market close

Revenue$47.4MMiss by $2.7M
EPS-$0.08Miss by $0.02
Revenue estimate$50.1M
EPS estimate-$0.06

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$43.7M
EPS estimate-$0.06

Financials

Q2 2025

Income statement

See full
Revenue$47.4M-31.7%
Gross profit$7.8M-74.8%
Operating income-$66.3M-393%
Net income-$39.6M-304%
EPS (diluted)-$0.27-286%

Balance sheet

See full
Cash & equivalents$269.9M-52.9%
Total debt$371.1M-34.0%
Total equity$265.9M-38.8%
Total assets$897.0M-37.9%

Cash flow

See full
Operating cash flow-$10.3M-159%
CapEx$2.9M-69.9%
Free cash flow-$13.1M—

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$321.07M-82.2%
Enterprise value$422.24M-76.4%
P/S1.5×-5.1×

Profitability

See full
Gross margin30.5%-15.3pp
Operating margin-145%-173pp
Net margin-87.6%+331pp

Returns & leverage

See full
Return on equity-55%+1,161pp
Debt / equity1.4×+0.1×
Current ratio5.2×-4.8×

Segments

By geography

See full
Europe, the Middle East and Africa$8.4M-38.5%
Asia Pacific$8.2M-65.2%
Latin and Central America$205.0K+69.4%

FAQ

When did Maravai LifeSciences Holdings, Inc. report Q2 2025 earnings?
Maravai LifeSciences Holdings, Inc. (MRVI) reported Q2 2025 earnings on August 11, 2025 after market close.
What were Maravai LifeSciences Holdings, Inc.'s Q2 2025 revenue and EPS?
Maravai LifeSciences Holdings, Inc. reported revenue of $47.4M and eps of $-0.08 for Q2 2025.
Did Maravai LifeSciences Holdings, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $50.1M by $2.7M. EPS missed the consensus estimate of $-0.06 by $0.02.
How did Maravai LifeSciences Holdings, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 35.4% from $73.4M a year earlier and eps grew 0.0% from $-0.08.
Where can I find Maravai LifeSciences Holdings, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001823239-25-000105) and the 10-Q periodic report (0001823239-25-000107) directly on SEC EDGAR. The filing index links above go to sec.gov.